List of articles with "Immunotherapy"

Weill Cancer Hub East

Weill Cancer Hub East

United States New York Cancer Research Immunotherapy Weill Family Foundation
iOncologi Acquires TargImmune

iOncologi Acquires TargImmune

United States Gainesville Immunotherapy iOncologi TargImmune
Luminary's CAR T Therapy

Luminary's CAR T Therapy

United States Minneapolis Immunotherapy Luminary Therapeutics CAR T
Compugen Fireside Chat

Compugen Fireside Chat

United States Immunotherapy Compugen Miami Beach CGEN
FDA Approves Fapon Biopharma Drug

FDA Approves Fapon Biopharma Drug

China Immunotherapy Dongguan Fapon Biopharma FP008
FP008 FDA Approval

FP008 FDA Approval

USA Immunotherapy Dongguan Fapon Biopharma FP008
FP008 Receives FDA Approval

FP008 Receives FDA Approval

USA Immunotherapy Dongguan Fapon Biopharma FP008
Immunotherapy FP008 Approved

Immunotherapy FP008 Approved

China Immunotherapy Dongguan Fapon Biopharma FP008
OncoHost & Gustave Roussy

OncoHost & Gustave Roussy

Israel Immunotherapy OncoHost Binyamina Gustave Roussy
HPV16 HNSCC Market Growth

HPV16 HNSCC Market Growth

None Immunotherapy HPV16 HNSCC
Oncolytics Nasdaq Notification

Oncolytics Nasdaq Notification

United States NASDAQ San Diego Immunotherapy Oncolytics Biotech
AbbVie Xilio Collaboration

AbbVie Xilio Collaboration

United States Immunotherapy AbbVie North Chicago Xilio Therapeutics
BioVaxys Private Placement

BioVaxys Private Placement

Canada Vancouver Immunotherapy Private Placement BioVaxys
ANT308 Breakthrough

ANT308 Breakthrough

USA Atlanta Immunotherapy Cambium Oncology ANT308
Cambium Oncology's ANT308

Cambium Oncology's ANT308

USA Atlanta Immunotherapy Cambium Oncology ANT308
Funding for ANT308!

Funding for ANT308!

USA Immunotherapy Delaware Cambium Oncology ANT308
ANT308: A Cancer Breakthrough

ANT308: A Cancer Breakthrough

USA Atlanta Immunotherapy Cambium Oncology ANT308
BioVaxys Extends Closing

BioVaxys Extends Closing

Canada Vancouver Immunotherapy BioVaxys DPX Technology
Cancer Therapy Breakthroughs

Cancer Therapy Breakthroughs

USA Vancouver Cancer Research Immunotherapy Oncolytics Biotech
Diamyd® Market Potential

Diamyd® Market Potential

Sweden Immunotherapy Stockholm Type 1 Diabetes Diamyd Medical
Diamyd® U.S. Potential

Diamyd® U.S. Potential

Sweden Immunotherapy Stockholm Diamyd Medical Diamyd®
Immunotherapy Acquisition

Immunotherapy Acquisition

United States San Francisco Immunotherapy biotechnology Foundery
TC BioPharm Trading Surge

TC BioPharm Trading Surge

NASDAQ United Kingdom Immunotherapy Edinburgh TC BioPharm
First Patient Dosing of HX044

First Patient Dosing of HX044

Immunotherapy HX044 Hanx Biopharmaceuticals
Cancer Treatment Revolution

Cancer Treatment Revolution

USA Vancouver Immunotherapy Cancer Treatments Oncolytics Biotech
Innovative Cancer Therapies

Innovative Cancer Therapies

USA Vancouver Immunotherapy Cancer Treatments Oncolytics Biotech
Advances in Cancer Immunotherapy

Advances in Cancer Immunotherapy

USA Vancouver Cancer Treatment Immunotherapy Oncolytics Biotech
Revolutionizing Cancer Care

Revolutionizing Cancer Care

USA Vancouver Cancer Treatment Immunotherapy Oncolytics Biotech
Immunotherapy Breakthroughs

Immunotherapy Breakthroughs

United States Vancouver Cancer Research Immunotherapy Oncolytics Biotech
Oncology Innovations in 2024

Oncology Innovations in 2024

USA Vancouver Cancer Research Immunotherapy Oncolytics Biotech
Kazia Presents New Data

Kazia Presents New Data

Immunotherapy Australia Sydney Kazia Therapeutics Paxalisib
BioVaxys Lowers Unit Price

BioVaxys Lowers Unit Price

Immunotherapy Private Placement BioVaxys
Follicular Lymphoma Advances

Follicular Lymphoma Advances

None Immunotherapy Follicular Lymphoma CAR T-cell Therapy
Dr. Sadeh Joins Scinai

Dr. Sadeh Joins Scinai

Israel Jerusalem Immunotherapy Scinai Jonathan Sadeh
BH3120 Cancer Therapy

BH3120 Cancer Therapy

South Korea Seoul Hanmi Pharmaceutical BH3120 Immunotherapy
Progress on BH3120 Immunotherapy

Progress on BH3120 Immunotherapy

South Korea Seoul Hanmi Pharmaceutical BH3120 Immunotherapy
Hanmi's BH3120 Trials

Hanmi's BH3120 Trials

South Korea Seoul Hanmi Pharmaceutical BH3120 Immunotherapy
BH3120 Cancer Trials

BH3120 Cancer Trials

South Korea Seoul Hanmi Pharmaceutical BH3120 Immunotherapy

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.